Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 1/2020

01-03-2020 | Pulmonary-Function Tests | Original Article

Duration of type 2 diabetes mellitus and pulmonary function tests: a correlative study

Authors: Swati Mittal, Manisha Jindal, Saurabh Srivastava, Arun Garg

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2020

Login to get access

Abstract

Background

Diabetes mellitus (DM) encompasses a group of metabolic disorders characterized by elevated levels of plasma glucose leading to macro- and micro-vascular damages to target organs. According to IDF, India had 73 million population of diabetes in 2017, and this figure may rise to 134 million adults by 2045 International Diabetes Federation, 2017. Since the alveolar capillary network in the lung is a large micro-vascular unit, microangiopathy may be targeting lungs along with other organs.

Objective

To correlate pulmonary function tests with duration of type 2 diabetes mellitus.

Method

The cross-sectional study was conducted on one hundred six patients of type 2 diabetes mellitus who met the inclusion and exclusion criteria. Diabetic cases were categorized on the basis of duration of disease. RMS Helios 401 computerized spirometer was used to assess pulmonary functions. Statistical tests employed include t test, ANOVA, and correlation coefficient analysis.

Result

The mean duration of disease for patients with diabetes was 10.17 ± 5.16 year. There was a significant negative correlation between the parameters of lung function test (p value < 0.05) with duration of diabetes.

Conclusion

We found that pulmonary functions have inverse relationship with increase in duration of type 2 diabetes mellitus.
Literature
1.
go back to reference Gerich JE. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocrine Reviews. 1998;19(4):491–503.CrossRef Gerich JE. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocrine Reviews. 1998;19(4):491–503.CrossRef
2.
go back to reference Dan L. Longo, Dennis L. Kasper, J. Larry Jameson, Anthony S. Fauci, Stephen L. Hauser, Joseph Loscalzo. Harrison’s principles of internal medicine. 18th edition. U.S.A.; 2012. Chapter 344, Diabetes Mellitus; p. 2968-2978 Dan L. Longo, Dennis L. Kasper, J. Larry Jameson, Anthony S. Fauci, Stephen L. Hauser, Joseph Loscalzo. Harrison’s principles of internal medicine. 18th edition. U.S.A.; 2012. Chapter 344, Diabetes Mellitus; p. 2968-2978
3.
go back to reference International Diabetes Federation, 2017, Eighth edition, 2017,ISBN: 978-2-930229-87-4 International Diabetes Federation, 2017, Eighth edition, 2017,ISBN: 978-2-930229-87-4
4.
go back to reference Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type II diabetes: Indian scenario. The Indian Journal of Medical Research. 2007;125:217–30.PubMed Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type II diabetes: Indian scenario. The Indian Journal of Medical Research. 2007;125:217–30.PubMed
5.
go back to reference Sandler M. Is the lung is target organ in diabetes mellitus? Archives of Internal Medicine. 1990;150:1385–8.CrossRef Sandler M. Is the lung is target organ in diabetes mellitus? Archives of Internal Medicine. 1990;150:1385–8.CrossRef
6.
go back to reference Marvisi M, Bartolini L, del Borrello P, Brianti M, Marani G, Guariglia A, et al.. Pulmonary function in non-insulin dependent diabetes mellitus. Respiration. 2001;68:268–72.CrossRef Marvisi M, Bartolini L, del Borrello P, Brianti M, Marani G, Guariglia A, et al.. Pulmonary function in non-insulin dependent diabetes mellitus. Respiration. 2001;68:268–72.CrossRef
7.
go back to reference Ford ES, Mannino DM. National Health and Nutrition Examination Survey Epidemiologic Follow-up Study Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care. 2004;27(12):2966–70.CrossRef Ford ES, Mannino DM. National Health and Nutrition Examination Survey Epidemiologic Follow-up Study Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care. 2004;27(12):2966–70.CrossRef
8.
go back to reference Hamlin CR, Kohn RR, Luschin JH. Apparent accelerated aging of human collagen in diabetes mellitus. Diabetes. 1975;24(10):902–4.CrossRef Hamlin CR, Kohn RR, Luschin JH. Apparent accelerated aging of human collagen in diabetes mellitus. Diabetes. 1975;24(10):902–4.CrossRef
9.
go back to reference Forgarty AW, Jones S, Britton JR, Lewis SA, McKeever TM. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax. 2007;62:515–20.CrossRef Forgarty AW, Jones S, Britton JR, Lewis SA, McKeever TM. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax. 2007;62:515–20.CrossRef
10.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.. Standardization of spirometry. The European Respiratory Journal. 2005;26:319–38.CrossRef Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.. Standardization of spirometry. The European Respiratory Journal. 2005;26:319–38.CrossRef
11.
go back to reference Walter RE, Beiser A, Givelber RJ, O’Connor GT, Gottlieb DJ. Association between glycemic state and lung function: the Framingham Heart Study. American Journal of Respiratory and Critical Care Medicine. 2003;167:911–6.CrossRef Walter RE, Beiser A, Givelber RJ, O’Connor GT, Gottlieb DJ. Association between glycemic state and lung function: the Framingham Heart Study. American Journal of Respiratory and Critical Care Medicine. 2003;167:911–6.CrossRef
12.
go back to reference Davis WA, Knuiman M, Kendall P, Grange V, Davis TM. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes, the fremantle diabetes study. Diabetes Care. 2004;27:752–7.CrossRef Davis WA, Knuiman M, Kendall P, Grange V, Davis TM. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes, the fremantle diabetes study. Diabetes Care. 2004;27:752–7.CrossRef
13.
go back to reference Hsin-Chieh Y, Naresh MP, Nae-Yuh W, et al.. Cross sectional and prospective study of lung function in adults with type 2 diabetes. Diabetes Care. 2008;31:741–6.CrossRef Hsin-Chieh Y, Naresh MP, Nae-Yuh W, et al.. Cross sectional and prospective study of lung function in adults with type 2 diabetes. Diabetes Care. 2008;31:741–6.CrossRef
14.
go back to reference Davis TM, Knuiman M, Kendall P, Vu H, Davis WA. Reduced pulmonary function and its association in type 2 diabetes: the Fremantle diabetes study. Diabetes Research and Clinical Practice. 2000;50:153–9.CrossRef Davis TM, Knuiman M, Kendall P, Vu H, Davis WA. Reduced pulmonary function and its association in type 2 diabetes: the Fremantle diabetes study. Diabetes Research and Clinical Practice. 2000;50:153–9.CrossRef
15.
go back to reference Mori H, Okubo M, Okamura M, Yamane K, Kado S, Egusa G, et al.. Abnormalities of pulmonary function in patients with non-insulin dependent diabetes mellitus. Internal Medicine. 1992;31:189–93.CrossRef Mori H, Okubo M, Okamura M, Yamane K, Kado S, Egusa G, et al.. Abnormalities of pulmonary function in patients with non-insulin dependent diabetes mellitus. Internal Medicine. 1992;31:189–93.CrossRef
16.
go back to reference Shah SH, Sonawane P, Nahar P, Vaidya S, Salvi S. Pulmonary function tests in type 2 diabetes mellitus and their association with glycemic control and duration of the disease. Lung India. 2013;30(2):108–12.CrossRef Shah SH, Sonawane P, Nahar P, Vaidya S, Salvi S. Pulmonary function tests in type 2 diabetes mellitus and their association with glycemic control and duration of the disease. Lung India. 2013;30(2):108–12.CrossRef
17.
go back to reference Ali MO, Begum S, Ali T, Ferdousi S. FVC, FEV 1 , and FEV 1/FVC% in type 2 diabetes and their relationships with duration of the disease. Journal of Bangladesh Society of Physiologist. 2009;4(2):81–7. Ali MO, Begum S, Ali T, Ferdousi S. FVC, FEV 1 , and FEV 1/FVC% in type 2 diabetes and their relationships with duration of the disease. Journal of Bangladesh Society of Physiologist. 2009;4(2):81–7.
18.
go back to reference Sreeja CK, Elizabeth Samuel C, Kesavachandran C, Shashidhar S. Pulmonary function in patients with diabetes mellitus. IJPP. 2003;47(1):87–93. Sreeja CK, Elizabeth Samuel C, Kesavachandran C, Shashidhar S. Pulmonary function in patients with diabetes mellitus. IJPP. 2003;47(1):87–93.
19.
go back to reference Meo SA, Al Drees AM, Arif M, Al-Rubean K. Lung function in type 2 Saudi diabetic patients. Saudi Medical Journal. 2006;27(3):338–43.PubMed Meo SA, Al Drees AM, Arif M, Al-Rubean K. Lung function in type 2 Saudi diabetic patients. Saudi Medical Journal. 2006;27(3):338–43.PubMed
20.
go back to reference Meo SA, Al Drees AM, et al.. Effect of duration of disease on ventilator function in an ethnic Saudi group of diabetics patients. Journal of Diabetes Science and Technology. 2007;5(1):711–7.CrossRef Meo SA, Al Drees AM, et al.. Effect of duration of disease on ventilator function in an ethnic Saudi group of diabetics patients. Journal of Diabetes Science and Technology. 2007;5(1):711–7.CrossRef
21.
go back to reference Verma S, Goni M, Kudyar RP. Assessment of pulmonary functions in patients with diabetes mellitus. JK Science. 2009;11(2):71–4. Verma S, Goni M, Kudyar RP. Assessment of pulmonary functions in patients with diabetes mellitus. JK Science. 2009;11(2):71–4.
22.
go back to reference Ali MO, Begum S, Begum N, Ali T. Ferdousi S.PEFR and FEF25-75%in type 2 diabetes mellitus and their relationships with its duration. J Bangladesh SocPhysiol. 2010;5(1):14–9.CrossRef Ali MO, Begum S, Begum N, Ali T. Ferdousi S.PEFR and FEF25-75%in type 2 diabetes mellitus and their relationships with its duration. J Bangladesh SocPhysiol. 2010;5(1):14–9.CrossRef
23.
go back to reference Panpalia NG, Kulkarni S, Aundhkar SC, Agrawal S. To study the effects of diabetes mellitus on pulmonary function tests. International Journal of Health Sciences & Research. 2014;4(5):108–119. (www.ijhsr.org). Accessed 2/08/2018 Panpalia NG, Kulkarni S, Aundhkar SC, Agrawal S. To study the effects of diabetes mellitus on pulmonary function tests. International Journal of Health Sciences & Research. 2014;4(5):108–119. (www.​ijhsr.​org). Accessed 2/08/2018
24.
go back to reference Yadav A, Saxena AK, Gaur K, Punjabi P, Meena G. Study of pulmonary function tests in type 2 diabetes mellitus: case control study. Journal of Dental and Medical Sciences (IOSR-JDMS). 2013;10(5):74–7.CrossRef Yadav A, Saxena AK, Gaur K, Punjabi P, Meena G. Study of pulmonary function tests in type 2 diabetes mellitus: case control study. Journal of Dental and Medical Sciences (IOSR-JDMS). 2013;10(5):74–7.CrossRef
25.
go back to reference Guleria SSR, Misra A, Pandey RM, Yadav R, Tiwari S. Pulmonary functions in patients with type 2 diabetes mellitus & correlation with anthropometry & micro-vascular complications Indian. Journal of Medical Research. 2004;119:66–71. Guleria SSR, Misra A, Pandey RM, Yadav R, Tiwari S. Pulmonary functions in patients with type 2 diabetes mellitus & correlation with anthropometry & micro-vascular complications Indian. Journal of Medical Research. 2004;119:66–71.
Metadata
Title
Duration of type 2 diabetes mellitus and pulmonary function tests: a correlative study
Authors
Swati Mittal
Manisha Jindal
Saurabh Srivastava
Arun Garg
Publication date
01-03-2020
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2020
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-019-00759-6

Other articles of this Issue 1/2020

International Journal of Diabetes in Developing Countries 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.